Table 1 Sample description by patient group
Total | Placebo | Chromium | t-test or χ2 | |
|---|---|---|---|---|
N=31 | N=15 (48.4%) | N=16 (51.6%) | p-value | |
Patient Characteristics | ||||
Age (yrs) | 37.23 (10.97) | 38.60 (10.58) | 35.94 (11.53) | .51 |
Gender | .87 | |||
Male | 17 (54.8%) | 8 (53.5%) | 9 (56.3%) | -- |
Female | 14 (45.2%) | 7 (46.7%) | 7 (43.8%) | -- |
Ethnicity | .15 | |||
Non-Hispanic white | 18 (58.1%) | 7 (46.7%) | 11 (68.8%) | -- |
African American | 6 (19.4%) | 4 (26.7%) | 2 (12.5%) | -- |
Asian | 5 (16.1%) | 4 (26.7%) | 1 (6.3%) | -- |
Hispanic | 2 (6.5%) | 0 (0%) | 2 (12.5%) | -- |
BMI | 23.12 (3.09) | 22.68 (2.26) | 22.53 (3.74) | .45 |
Waist circumference (cm) | 79.54 (13.05) | 78.7 (6.93) | 80.27 (17.15) | .75 |
Fasting Glucose (mmol/L) | 4.81 (0.29) | 4.40 (0.27) | 4.55 (0.29) | .14 |
Total cholesterol (mmol/L) | 4.49 (0.13) | 4.41 (0.86) | 4.56 (0.82) | .61 |
Triglycerides (mmol/L) | 0.91 (0.40) | 0.82 (0.17) | 1.01 (0.53) | .21 |
LDL cholesterol (mmol/L) | 2.25 (0.55) | 2.15 (0.45) | 2.34 (0.63) | .35 |
HDL cholesterol (mmol/L) | 1.51 (0.40) | 1.6 (0.44) | 1.43 (0.35) | .24 |